Pulsenmore

Pulsenmore Acquisitions (Net)

The Acquisitions (Net) of Pulsenmore (PLSM.TA) as of Nov 21, 2026 is 59.09 M ILS. In the previous year, Acquisitions (Net) was 60.63 M ILS — a change of -2.54% (lower).

Acquisitions (Net)

59.09 MILS

YoY

-2.54%

Last updated:

Acquisitions (Net) of Pulsenmore is 2024 59.09 M ILS. Acquisitions (Net) of Pulsenmore was 2023 60.63 M ILS. It decreases by -2.54% lower compared to the previous year.

The Pulsenmore Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2019
10,000.00 ILS
Jan 1, 2020
-10,000.00 ILS
Jan 1, 2021
-40.58 M ILS
Jan 1, 2022
-120.05 M ILS
Jan 1, 2023
60.63 M ILS
Jan 1, 2024
59.09 M ILS
The Pulsenmore Acquisitions (Net) history
YEARAcquisitions (Net)YoY
59.09 MILS-2.54%
60.63 MILS-150.51%
-120.05 MILS+195.83%
-40.58 MILS+405,700.00%
-10,000.00ILS-200.00%
10,000.00ILS—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

Acquisitions (Net) of Pulsenmore is 59.09 M ILS in 2024.

Acquisitions (Net) of Pulsenmore changed from 60.63 M ILS to 59.09 M ILS, representing a -2.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s ILS is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Pulsenmore historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Pulsenmore

All Key Metrics — Pulsenmore